See more : PT Semen Indonesia (Persero) Tbk (PSGTF) Income Statement Analysis – Financial Results
Complete financial analysis of LOTTE Fine Chemical Co., Ltd. (004000.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LOTTE Fine Chemical Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- AJR Infra and Tolling Limited (AJRINFRA.NS) Income Statement Analysis – Financial Results
- Laxmi Goldorna House Ltd (LGHL.NS) Income Statement Analysis – Financial Results
- Victory Capital Holdings, Inc. (VCTR) Income Statement Analysis – Financial Results
- Himalaya Shipping Ltd (HSHPO.XD) Income Statement Analysis – Financial Results
- ReadyTech Holdings Limited (RDY.AX) Income Statement Analysis – Financial Results
LOTTE Fine Chemical Co., Ltd. (004000.KS)
About LOTTE Fine Chemical Co., Ltd.
LOTTE Fine Chemical Co., Ltd. manufactures and sells chemical products in Korea. It offers cellulose relatives, including MECELLOSE, hydroxyethyl cellulose, AnyCoat-C (hypromellose), and AnyCoat-P (hypromellose phthalate) for use in various fields, such as construction, cement extrusion, ceramic extrusion, paint, medicine, and household items. The company also provides epichlorohydrin, caustic soda, methyl and methylene chloride, chloroform, sodium hypochlorite, methaclean, hydrochloric acid, and PTAC for use in architecture, textiles, and resins industries. In addition, it offers general chemicals, which include EUROX, ammonia, ammonium hydroxide, monomethyl amine, dimethylamine, trimethylamine, and trimethylamine-HCl; tetramethyl ammonium hydroxide, a material for semiconductor; and polymerized toners for color laser printers. The company was formerly known as SAMSUNG Fine Chemicals Co., Ltd. changed its name to LOTTE Fine Chemical Co., Ltd. in 2016. LOTTE Fine Chemical Co., Ltd. was founded in 1964 and is headquartered in Ulsan, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,768.62B | 2,463.76B | 1,780.29B | 1,263.64B | 1,311.27B | 1,371.70B | 1,159.51B | 1,110.70B | 1,161.86B | 1,210.50B | 1,314.06B | 1,431.16B | 1,333.62B | 1,130.03B | 1,038.40B | 1,130.89B | 829.35B |
| Cost of Revenue | 1,496.01B | 1,938.38B | 1,431.10B | 1,029.57B | 1,027.79B | 1,071.49B | 949.29B | 947.93B | 1,031.10B | 1,093.67B | 1,205.78B | 1,266.23B | 1,174.15B | 989.84B | 880.35B | 945.42B | 738.11B |
| Gross Profit | 272.61B | 525.38B | 349.19B | 234.06B | 283.48B | 300.20B | 210.22B | 162.77B | 130.76B | 116.83B | 108.28B | 164.93B | 159.47B | 140.19B | 158.04B | 185.47B | 91.24B |
| Gross Profit Ratio | 15.41% | 21.32% | 19.61% | 18.52% | 21.62% | 21.89% | 18.13% | 14.65% | 11.25% | 9.65% | 8.24% | 11.52% | 11.96% | 12.41% | 15.22% | 16.40% | 11.00% |
| Research & Development | 17.19B | 14.62B | 13.18B | 12.03B | 11.37B | 11.93B | 11.27B | 11.78B | 25.16B | 29.75B | 36.93B | 26.26B | 17.07B | 8.16B | 4.11B | 5.01B | 4.71B |
| General & Administrative | 44.38B | 10.38B | 6.83B | 6.85B | 8.55B | 6.82B | 11.18B | 12.34B | 17.15B | 16.74B | 18.72B | 13.94B | 17.78B | 5.33B | 4.55B | 4.96B | 4.37B |
| Selling & Marketing | 56.15B | 58.12B | 48.24B | 41.35B | 39.72B | 36.14B | 44.98B | 40.79B | 42.32B | 44.94B | 36.24B | 41.27B | 26.44B | 40.21B | 39.70B | 41.35B | 38.81B |
| SG&A | 100.53B | 68.50B | 55.06B | 48.20B | 48.27B | 42.96B | 56.16B | 53.12B | 59.47B | 61.68B | 54.95B | 55.21B | 44.23B | 45.54B | 44.25B | 46.31B | 43.18B |
| Other Expenses | 0.00 | 37.95B | 36.36B | 30.48B | 32.23B | 6.31B | -15.64B | -1.87B | 117.03B | 27.65B | 18.15B | 14.07B | 3.20B | 9.15B | -1.27B | -3.01B | 1.69B |
| Operating Expenses | 117.73B | 121.07B | 104.60B | 90.71B | 91.87B | 101.61B | 99.09B | 133.02B | 128.21B | 141.19B | 128.62B | 109.35B | 86.96B | 79.48B | 67.33B | 69.28B | 62.10B |
| Cost & Expenses | 1,614.04B | 2,059.45B | 1,535.71B | 1,120.29B | 1,119.66B | 1,173.10B | 1,048.39B | 1,080.95B | 1,159.31B | 1,234.85B | 1,334.40B | 1,375.58B | 1,261.11B | 1,069.32B | 947.68B | 1,014.70B | 800.21B |
| Interest Income | 56.86B | 13.04B | 1.36B | 5.52B | 7.44B | 6.14B | 5.24B | 3.34B | 4.67B | 2.10B | 1.81B | 2.90B | 5.25B | 7.78B | 5.66B | 8.29B | 7.75B |
| Interest Expense | 837.24M | 571.38M | 359.35M | 987.80M | 2.10B | 4.54B | 10.00B | 10.19B | 13.35B | 18.22B | 6.13B | 82.34M | 560.20M | 0.00 | 13.51M | 70.51M | 139.09M |
| Depreciation & Amortization | 138.56B | 123.54B | 120.25B | 105.96B | 92.15B | 80.90B | 75.64B | 81.55B | 73.28B | 70.29B | 59.06B | 66.20B | 64.57B | 52.36B | 49.18B | 51.37B | 59.81B |
| EBITDA | 293.34B | 74.83B | 635.51B | 334.48B | 287.74B | 281.82B | 182.79B | 26.31B | 75.34B | 45.93B | 38.72B | 152.38B | 152.91B | 113.07B | 153.00B | 161.59B | 110.13B |
| EBITDA Ratio | 16.59% | 34.27% | 29.94% | 25.47% | 25.10% | 27.10% | 17.28% | 11.63% | 18.45% | 11.74% | 4.93% | 10.54% | 12.06% | 9.63% | 16.13% | 13.20% | 14.04% |
| Operating Income | 154.78B | 720.61B | 412.21B | 215.30B | 189.67B | 210.71B | 111.13B | 29.75B | 2.55B | -24.36B | -20.34B | 55.58B | 72.31B | 60.71B | 90.71B | 116.19B | 29.14B |
| Operating Income Ratio | 8.75% | 29.25% | 23.15% | 17.04% | 14.46% | 15.36% | 9.58% | 2.68% | 0.22% | -2.01% | -1.55% | 3.88% | 5.42% | 5.37% | 8.74% | 10.27% | 3.51% |
| Total Other Income/Expenses | 97.99B | -244.23B | 334.65B | 44.22B | 35.21B | 64.50B | -5.17B | -80.14B | 110.17B | 94.78B | 20.64B | 30.52B | 15.47B | 43.33B | 13.09B | -6.04B | 21.04B |
| Income Before Tax | 252.77B | 160.08B | 746.85B | 259.52B | 224.87B | 275.21B | 110.68B | -50.39B | 112.73B | 70.42B | 292.17M | 86.10B | 87.78B | 104.04B | 103.80B | 110.15B | 50.18B |
| Income Before Tax Ratio | 14.29% | 6.50% | 41.95% | 20.54% | 17.15% | 20.06% | 9.55% | -4.54% | 9.70% | 5.82% | 0.02% | 6.02% | 6.58% | 9.21% | 10.00% | 9.74% | 6.05% |
| Income Tax Expense | 70.74B | 13.92B | 161.39B | 60.73B | 56.50B | 60.29B | 21.45B | -6.85B | 22.75B | 11.74B | -3.05B | 12.82B | 14.36B | 18.87B | 17.13B | 24.86B | 10.10B |
| Net Income | 182.03B | 146.16B | 585.46B | 198.79B | 168.37B | 214.92B | 89.23B | -43.55B | 93.87B | 61.17B | 3.34B | 73.28B | 73.43B | 85.17B | 86.67B | 85.29B | 40.08B |
| Net Income Ratio | 10.29% | 5.93% | 32.89% | 15.73% | 12.84% | 15.67% | 7.70% | -3.92% | 8.08% | 5.05% | 0.25% | 5.12% | 5.51% | 7.54% | 8.35% | 7.54% | 4.83% |
| EPS | 7.15K | 5.74K | 22.99K | 7.80K | 6.61K | 8.44K | 3.50K | -1.71K | 3.69K | 2.40K | 131.00 | 2.88K | 2.89K | 3.36K | 3.43K | 3.38K | 1.58K |
| EPS Diluted | 7.15K | 5.74K | 22.99K | 7.80K | 6.61K | 8.44K | 3.50K | -1.71K | 3.69K | 2.40K | 131.00 | 2.88K | 2.89K | 3.35K | 3.41K | 3.36K | 1.57K |
| Weighted Avg Shares Out | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.50M | 25.46M | 25.42M | 25.34M | 25.30M | 25.25M | 25.37M |
| Weighted Avg Shares Out (Dil) | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.47M | 25.50M | 25.47M | 25.45M | 25.42M | 25.41M | 25.40M | 25.53M |
Source: https://incomestatements.info
Category: Stock Reports